These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33112626)

  • 1. HDX and In Silico Docking Reveal that Excipients Stabilize G-CSF via a Combination of Preferential Exclusion and Specific Hotspot Interactions.
    Wood VE; Groves K; Cryar A; Quaglia M; Matejtschuk P; Dalby PA
    Mol Pharm; 2020 Dec; 17(12):4637-4651. PubMed ID: 33112626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Engineering and HDX Identify Structural Regions of G-CSF Critical to Its Stability and Aggregation.
    Wood VE; Groves K; Wong LM; Kong L; Bird C; Wadhwa M; Quaglia M; Matejtschuk P; Dalby PA
    Mol Pharm; 2022 Feb; 19(2):616-629. PubMed ID: 34965730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the Solid-State Interactions in Lyophilized Human G-CSF Using Hydrogen-Deuterium Exchange Mass Spectrometry.
    Wood VE; Kellerman MA; Groves K; Quaglia M; Topp EM; Matejtschuk P; Dalby PA
    Mol Pharm; 2024 Apr; 21(4):1965-1976. PubMed ID: 38516985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Characterization of Antibody-Excipient Interactions for Rational Excipient Selection Using the Site Identification by Ligand Competitive Saturation-Biologics Approach.
    Jo S; Xu A; Curtis JE; Somani S; MacKerell AD
    Mol Pharm; 2020 Nov; 17(11):4323-4333. PubMed ID: 32965126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Stabilization and Destabilization of Protein Domains in Tissue-Type Plasminogen Activator Using Formulation Excipients.
    Robinson MJ; Matejtschuk P; Longstaff C; Dalby PA
    Mol Pharm; 2019 Feb; 16(2):744-755. PubMed ID: 30565948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of excipients is a poor predictor for aggregation kinetics of biopharmaceutical proteins.
    Zalar M; Svilenov HL; Golovanov AP
    Eur J Pharm Biopharm; 2020 Jun; 151():127-136. PubMed ID: 32283214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-State Hydrogen-Deuterium Exchange Mass Spectrometry (ssHDX-MS) of Lyophilized Poly-d,l-Alanine.
    Kammari R; Topp EM
    Mol Pharm; 2019 Jul; 16(7):2935-2946. PubMed ID: 31244225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Protein-Excipient Interaction Hotspots Using Computational Approaches.
    Barata TS; Zhang C; Dalby PA; Brocchini S; Zloh M
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27258262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of Globular Protein Thermal Stability in Aqueous Formulations by the Positively Charged Amino Acid Excipients.
    Platts L; Darby SJ; Falconer RJ
    J Pharm Sci; 2016 Dec; 105(12):3532-3536. PubMed ID: 27776770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Hydrogen Exchange Mass Spectrometry as a Stability-Indicating Method for Formulation Excipient Screening for an IgG4 Monoclonal Antibody.
    Toth RT; Pace SE; Mills BJ; Joshi SB; Esfandiary R; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2018 Apr; 107(4):1009-1019. PubMed ID: 29269271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sucrose and benzyl alcohol on GCSF conformational dynamics revealed by hydrogen deuterium exchange mass spectrometry.
    Zhang J; Banks DD; He F; Treuheit MJ; Becker GW
    J Pharm Sci; 2015 May; 104(5):1592-600. PubMed ID: 25693946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring Effects of Excipients, Formulation Parameters and Mutations on the High Order Structure of Filgrastim by NMR.
    Aubin Y; Hodgson DJ; Thach WB; Gingras G; Sauvé S
    Pharm Res; 2015 Oct; 32(10):3365-75. PubMed ID: 26043856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of drying method and excipient on structure and stability of protein solids using solid-state hydrogen/deuterium exchange mass spectrometry (ssHDX-MS).
    Wilson NE; Topp EM; Zhou QT
    Int J Pharm; 2019 Aug; 567():118470. PubMed ID: 31252148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the Protein-Excipient Interaction in the Orally Delivered Protein by Solid-State Hydrogen-Deuterium Exchange Mass Spectrometry and Molecular Dynamics.
    Pan X; Lenka S; Davis J; Nagapudi K; Mantik P; Saggu M; Dai L; Cadang L; Zhang HM; Zhang J; Izadi S; Yang F; Wei B
    Anal Chem; 2024 Jan; 96(2):802-809. PubMed ID: 38155586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of Electrostatic Mediated Antibody Liquid-Liquid Phase Separation by Charged and Noncharged Preferentially Excluded Excipients.
    Banks DD; Cordia JF
    Mol Pharm; 2021 Mar; 18(3):1285-1292. PubMed ID: 33555888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid formulation assessment of filgrastim therapeutics by a thermal stress test.
    Alebouyeh M; Tahzibi A; Yaghoobzadeh S; Zahedy ET; Kiumarsi S; Soltanabad MH; Shahbazi S; Amini H
    Biologicals; 2016 May; 44(3):150-6. PubMed ID: 27017583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
    Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
    Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of aggregation breakers for bevacizumab (Avastin®) self-association through similarity searching and interaction studies.
    Westermaier Y; Veurink M; Riis-Johannessen T; Guinchard S; Gurny R; Scapozza L
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):773-80. PubMed ID: 23665445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 1.
    Hu Y; Arora J; Joshi SB; Esfandiary R; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2020 Jan; 109(1):340-352. PubMed ID: 31201906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein.
    Wen L; Zheng X; Wang X; Lan H; Yin Z
    Pharm Res; 2017 Jul; 34(7):1378-1390. PubMed ID: 28401430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.